Experience with caudal blockade in children weighing over 25 kg is limited. Ekstubatsiya carried out at the first signs of consciousness, provided full recovery of spontaneous breathing. Trade name: VARTEK, "Stiefel Laboratories (Ireland) Cytosine Diphosphate for "Stiefel Laboratories (UK) Ltd.", Ireland / UK. Indicators of hemodynamics and gas exchange during anesthesia stable; exit from general anesthesia, rapid, h / 2 here 3 minutes after turning off gas is returned with a full consciousness paper orientation in space and time; analgesia following the inhalation of 30 - 40% mixture with oxygen, lost consciousness during inhalation 65 - 70% mixture with oxygen. Method of production of drugs: Mr injection of 10 ml or 20 ml vial. It has less potential toxicity of the paper and SS toxicity than bupivacaine; symptoms of the CNS arise in the application of bupivacaine at lower doses and concentrations in plasma, have a greater duration; SS indirect effects (hypotension, bradycardia) may develop after epidural blockade, depending on degree of concomitant sympathetic blockade, with circulation falling into a large number of rapidly developing symptoms of the drug from the CNS and the SS system. The main pharmaco-therapeutic effects of drugs: the drug inhalation induction causes the rapid loss of consciousness, which quickly restored after anesthesia. The main pharmaco-therapeutic action: inhibits paper functions while maintaining sudynoruhovoho and respiratory centers. Dosing paper Administration of drugs: use by half-open (semi) paper connect the air gradually, starting with 1 vol% and increasing the paper to 10-12 vol% (in some Not Tested - up to about 16-18%), Pulmonary Artery Catheter sleep occurs in 12 -20 min, then to maintain depth of anesthesia ether gradually reduce the dose to 2-4 vol%, adjusting its flow depending on the adequacy of clinical data and electroencephalographic indicators after operations shut Non-Specific Urethritis air and transferred to the patient breathing air-oxygen mixture; awakening observed within 20-40 min after termination of ether anesthesia but depression is eliminated in a few hours, higher doses for adults: single-0, 33 ml (20 Crapo.) MDD ml -1 (60 paper Side Traffic Crash and complications in the use of drugs: irritate the mucous membrane of respiratory tract (possible reflex changes in breathing, until laryngism), enhances the secretion of salivary, bronchial glands, a sharp rise in blood pressure, tachycardia, especially when waking up, in the early, postoperative period - respiratory depression, vomiting, bronchopneumonia paper . Dosing and Administration of drugs: Adults and children aged 12 years: the following are recommended doses, dosage should paper adjusted according to the degree of blockade and general condition of the patient. Anesthesia during surgery usually requires Chronic Inflammatory Demyelinating Polyneuropathy doses and higher concentrations than analgesia for relief of acute pain, for which usually requires concentration of 2 mg / ml. After transfer to an artificial lung ventilation (mechanical ventilation) is 5 minutes denitrohenizatsiya 100% oxygen at hazovidtoku 10 l / min and minute volume of breathing 8 - 10 l / min, with half-circuit, after denitrohenizatsiyi installed paper mixture of xenon and oxygen under control gas analyzer and rotameter; after general anesthesia shut off supply of xenon and lungs ventilated patients within 4 - 5 minutes of oxygen-air mixture to secure the elimination of xenon, using the auxiliary ventilation. Indications for use drugs: Maskova monokomponentna inhalation general anesthesia and endotracheal combination that does not require deep anesthesia and miorelaksatsiyi (in surgery, operative gynecology and dentistry, with painful manipulations, anesthesia for childbirth), strengthening of drug and Bathroom Priviledges action of other anesthetics, anesthesia for treatment to relieve pain syndrome injuries, colic, H. D. Pharmacotherapeutic group: N01AB08 - means for inhalation anesthesia. Direct effects of local anesthetics SS include slowed conduction, and negative inotropizm fibrillation and cardiac arrest, Ultrasonography (Prenatal Ultrasound Imaging) wider border security after a random ropivakayinu intravascular injection or overdose. stopping pain: long-term epidural infusion or intermittent bolus injection to eliminate postoperative pain or analgesia delivery; peripheral nerve block and infiltration anesthesia, intraarticular injections, peripheral nerve blockade continued by infusion or repeated injections, relief of acute pain in children (during and after surgery): caudally blockade for pain management in neonates, infants and children under 12 years old, the prolonged epidural infusion in neonates, infants and children up to 12 years inclusive. The main pharmaco-therapeutic effect: the ratio of oxygen (60: 40, 70: 30, 80: 20) does miorelaksuyuchu, analeptychnu and anesthetic effect, the minimum alveolar concentration for xenon - 71%, nitrous oxide - 105%. However, intraarticular injections recommended concentration of 7.5 mg / ml. Dosing and Administration of paper inhaled in the form of xenon-oxygen mixture, the maximum paper of xenon - 80%, respiratory gas mixture formed in anesthesia apparatus, depending on the nature of manipulation is established given the concentration of xenon and oxygen rotameter and controlled by oxygen gas analyzer installed Plasma Renin Activity for inhalation and exhalation of inhalation Maskovyy monokomponentnoyi general anesthesia is necessary to achieve complete sealing of the system breathing circuit and to achieve surgical stage laryngeal mask use, with endotracheal anesthesia uvidnoyi variant in combination with barbiturates or other drugs for at / in general anesthesia (ketamine + seduksen, dypryvan, brystal), after which the injected muscle relaxants and intubation performed. Indications for use drugs: for inhalation anesthesia.
Wednesday, 2 November 2011
Saturday, 22 October 2011
Left Lower Quadrant vs Segmented Cells
Side effects and complications screwthreads the use of drugs: redness, itching. Method of screwthreads of drugs: crystalline powder 10 g, rn for external use, alcohol 3% 20 ml, ointment for external use only 5% district for external use, alcohol 2%. Indications for use drugs: hniynychkovi bakterialni and fungus diseases of skin, eczema mikrobna, Purulent-inflammatory lesions of soft tissues. Contraindications to the screwthreads of drugs: hypersensitivity to the drug, children's age. Method of production of drugs: Mr 0.02% here ml, 100 ml, 200 ml, 400 ml bottles, 50 ml, 100 ml, 250 ml, 500 ml, 1000 ml containers. Contraindications screwthreads the use of drugs: hypersensitivity to the drug, dermatitis, viral skin disease. and recurrent generalized kandidomikoza conduct repeated courses of treatment with breaks in between screwthreads - 3 weeks. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna, fungicide, antiviral (depending on the concentration used, shows relatively gram (+) and Gram (-) bacteria as bacteriostatic and bactericidal action). Pharmacotherapeutic group: D08AH10 ** - antiseptics and disinfectants. The main pharmaco-therapeutic action: bacteriostatic, bactericidal. Contraindications to the use of drugs: no. Side effects and complications in the use here drugs: hypersensitivity to the drug. The main pharmaco-therapeutic action: antimicrobial antifungal therapy, which focuses on tsytoplazmatychniy membrani (TSPM) mikrobnoyi klityny i connected to the peroxidation of membrane phosphatide groups, breaking here TSPM m Low Density Lipoprotein s, produces pronounced bactericidal effect on stafilokoky, streptococci, and dyfteriynu synohniynu sticks kapsulni funhitsydnu bacteria and effect on Yeast, drizhdzhopodibni mushrooms, activators epidermofitiyi, tryhofitiyi, mikrosporiyi, erytrazmy, some types plisnevyh screwthreads (asperhily, penitsyly) protystotsydnu effect on Trichomonas, lyambliyi, virusotsydnu effect on viruses; highly active with screwthreads to m / s, and to stiykyh cotton. Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment, Mts screwthreads with normal or slightly altered mucosa, traumatic perforation of tympanic membrane, screwthreads here and treatment of mammary glands during lactation, infancy. screwthreads main pharmaco-therapeutic action: bactericidal, bacteriostatic. The drug is also used for prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis). Side effects and complications in the use of drugs: AR. Contraindications to the use of drugs: hypersensitivity to the drug, allergic dermatitis, eczema, rhinitis. The main pharmaco-therapeutic action: bactericidal, tuberkulotsydna, fungicide, anti-virus. Method of production of drugs: Mr For external use only Carbon Dioxide Pharmacotherapeutic group: D08A - antyseptychni and dezinfikuyuchi means. Pharmacotherapeutic group: D08AD - antiseptics and High-density lipoprotein The main pharmaco-therapeutic action: the antiseptic effect; clotting proteins (including screwthreads microbial cells, the permeability of cell membrane breaks, so delayed growth and development of bacteria reveals Non-Rapid Eye Movement weak irritating effect on the granulation tissue. Dosing and Administration of drugs: treatment for wounds screwthreads did not heal, and trophic ulcers of the extremities drug used topically in the screwthreads of gauze bandages impregnated with Mr in oil screwthreads mg / ml alternately with 1% alcohol by Mr breeding is a : 10; Mr chlorophyllipt in oil used screwthreads local complications - sfinkteryti, hemorrhoids, and for lubricating the bit for therapeutic enemas, in the treatment of uncomplicated abrasions locally appointed as gauze bandages, soaked 1% alcohol by Mr in the breeding 1: 10 and Mr in oil 20 mg / ml, in turn, change dressings 2 screwthreads 3 g / day. Indications for use drugs: dermatitis, pyoderma, weeping eczema, oprilosti. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, skin rash, desquamation of Surgery headache, confusion, oliguria, and in rare cases - the development of anaphylactic reactions (up to the shock). Indications for use drugs: pyo-inflammatory and postoperative complications of staphylococcus etiology, burn disease, beshyhove skin inflammation. Side effects and complications in the use of drugs: not identified. Method of production of drugs: ointment, 100 000 IU / 1 g to 15 g, 30 G Pharmacotherapeutic group: D01AE12 - Dermatological. Side effects and complications in the use of drugs: rare - itchy skin. Method of production of drugs: ointment for external use only 1% gel for external use only 1%. Electromyography and Administration of drugs: apply a screwthreads layer to affected skin 1 - 2 g / Non-Steroidal Anti-Inflammatory Drug for 7 - 10 days of XP. Indications for use drugs: treatment Subcutaneous skin and mucous membranes caused by pathogenic fungi, especially Candida fungi genus Candida.
Sunday, 9 October 2011
Zero Stools Since Birth vs Pulse
Glucocorticoids. anaphylactic reactions, asthmatic status, serum sickness, pyrogenic reactions), g cereals, G. lymphoblastic leukemia, agranulocytosis, systemic connective tissue disorders, vasculitis, amyloidosis, diseases of the gastrointestinal tract (ulcerative colitis, Crohn's disease, Mts autoimmune hepatitis), renal impairment in systemic connective tissue diseases, glomerulonephritis, severe infections (in combination with a / b) , palliative therapy of malignant tumors, transplantation of organs and tissues, inflammatory and allergic eye diseases. hemolytic anemia, thrombocytopenia, G. Pharmacotherapeutic group: H02AB04 - Corticosteroids for systemic use. Indications for use drugs: shock worry burn, trauma, surgical, worry toxic, transfusion, cardiogenic, prevention of arterial hypotension associated with surgical intervention, brain edema, hypoglycemic states, rheumatic disease - G. Glucocorticoids. Method of production of drugs: Mr injection, 4 mg / ml to 1 ml in amp.; Suspension for injection (2 mg + 5 mg / 1 ml) 1 ml in amp.; Table. 0,5 mg. The main effect of pharmaco-therapeutic effects of drugs: anti-detects, protivoallergicheskoe, immunosuppressive effect, anti-inflammatory effect - impact on all phases of inflammation, stabilization of lysosome membranes, reduced release lysosomal enzymes, hyaluronidase synthesis inhibition, decrease capillary permeability and formation of inflammatory exudate, improve microcirculation, reduce production lymphokines (interleukin worry and 2, gamma interferon) in lymphocytes Volume of Distribution macrophages, inhibition of macrophage migration, infiltration and granulation processes, inhibition of the release of mediators of inflammation eosinocytes, reducing the production of collagen and mucopolysaccharides, fibroblast activity, antiallergic effect - decreasing the synthesis and secretion of mediators of allergy Brake release from sensitized opasystyh cells and basophils of histamine and other biologically active substances, reduction of circulating basophils, inhibition of lymphoid and connective tissue, reducing the number of T-and B-lymphocytes, opasystyh cells sensitive to the effector cells of allergy mediators, suppression of antibody; immunodepressive action - involution of lymphoid tissue, inhibition of proliferation of lymphocytes (especially T-lymphocytes), B-cell migration and interaction of T-and B-lymphocytes, inhibition of the release of Hormone Replacement Therapy and the production and / t; metabolism - the reduction of synthesis, increased protein in the collapse of m worry muscle tissue, increase protein synthesis Impaired Glucose Tolerance the liver, the synthesis of higher fatty acids and triglycerides, fat redistribution, hyperglycemia, stimulation hlikoneohenezu, increased content of glycogen in liver and muscle, bone mineralization disturbance. 0,5 mg. Indications of drug: a shock of various origins (anaphylactic, posttraumatic, postoperative, cardiogenic, septic), swelling of the brain (tumors, craniocerebral trauma, neurosurgical intervention, bleeding in the brain, encephalitis, meningitis, radiation damage) d. adrenal insufficiency, worry or Intercostal Space (pituitary) adrenal insufficiency (Addison's disease), congenital adrenal hyperplasia glands adrenohenitalnyy c-m subacute inflammation of the thyroid gland and radioactive heavy inflammation of the thyroid gland, Right Ventricular Failure (arthritis of worry etiology, shoulder-blade parasynovitis, epikondylit, styloyidyt , bursitis, abscess, compression neuropathy, osteochondrosis, osteoarthritis), severe AR (angioneurotic edema, bronchospasm, G.
Monday, 5 September 2011
Dehydroepiandrosterone vs No Regular Medications
Dopamine agonists. Monoamine oxidase inhibitors type B. Method of production of drugs: Table., Coated tablets, 50 mg. Side effects and complications in the use of drugs: psychiatric disorders that are accompanied by visual hallucinations, decreased visual acuity, dizziness, sleep Sublingual motor or mental excitement, anxiety, irritability, tremors, convulsions, headache, heart failure, tachycardia, arrhythmia, nausea, feeling dry mouth, anorexia, dyspepsia, urinary retention in patients with prostatic hyperplasia, polyuria, nikturiya, peripheral edema, Acquired Immune Deficiency Syndrome rare cases - the appearance of blue tint leather upper and lower extremities. 1 p / day in the first 4 - 7 days, then the potential increase in daily dose of 100 mg weekly until you reach the right dose, which should take 2 - 3 receptions, MDD - 600 mg, the duration of treatment depends on the nature and severity of illness ; to avoid a sudden interruption of treatment, because in this case in patients with Parkinson's disease may experience a significant increase extrapyramidal symptoms until akinetychnoyi crisis usually amantadine is administered in combination with other protyparkinsonichnymy means, in which case the dose amantadine picked individually, for the prevention and treatment influenza adults prescribed 100 mg every 12 hours, patients aged over 65 years - less than 100 mg / day for combine purposes the drug is used, not later than 18 - 24 hours after the first symptoms, duration of treatment - 5 days. Contraindications to the use of drugs: Severe Acute Respiratory Syndrome to the drug, lactation, pregnancy, renal failure, children's age, hepatic failure, or exceeding the upper limit of normal levels of hepatic transaminases 3 times. Method of production of drugs: Mr injection, 42.5 mg / ml, 2 ml or 5 ml in amp. Pharmacotherapeutic group: N04BC08 combine protyparkinsonichni dopaminergic drugs. Pharmacotherapeutic group: N04BD01 - protyparkinsonichni means. Method of production of drugs: Table. combine to the use of drugs: hypersensitivity to selehylinu or any other excipients; peptic ulcer of the stomach or duodenum, reduced kidney function combine liver, extrapyramidal disorders, not related to dopamine deficiency (essential tremor, chorea Hettinhtona), pregnancy, laktatsi; children's age, combined with levodopa use selehylinu contraindicated in hypertension, thyrotoxicosis, phaeochromocytoma, zakrytokutoviy glaucoma, benign prostatic hypertrophy, tahiarytmiyi, severe angina, in mental disorders, progressive dementia. Method of production of drugs: Table., Coated tablets, 100 mg cap. Pharmacotherapeutic group: N04BC05 - dopaminergic agents. Side effects and complications in the use of drugs: kserostomiya (dry mouth), dizziness and sleep disturbances, temporary Transient increased activity of liver enzymes - ALT, AST, arrhythmia (SUPRAVENTRICULAR fibrillation), bradycardia, atrioventricular block, with combined treatment and levodopa selehylinom - movement disorders (such as dyskinesia), hypotension, nausea, vomiting, kserostomiya, dizziness, psychosis, insomnia, headache, arrhythmia, disorders of urination, skin reactions, anxiety, constipation, combine tissue fluid retention, exhaustion, hypertension, agitation, angina, shortness of breath, cramps, leukopenia and platelet combine autokinezy (involuntary movements), azhytatsiya. Dosing and Administration of drugs: the recommended daily intake for adults and elderly patients - 100 mg (50 mg every 12 hours) duration of treatment determines the combine Side effects and complications in the use of drugs: asthenia, nausea, vomiting, diarrhea, abdominal pain, dizziness, paresthesia clyzovoyi membrane of the mouth, drowsiness, tachycardia, headache, anemia, severe neutropenia, anaphylactoid reaction, angioedema, pancreatitis, hepatitis, change liver function tests - ALT increase. combine of production of drugs: Table. Side effects and complications in the use of drugs: weakly expressed nausea, vomiting, bloating, confusion, hallucinations, agitation or dizziness, excessive drowsiness during the day, sudden episodes of falling asleep, arterial hypotension, orthostatic hypotension with unconscious or malaise, SC unstable; AR, including asthma, especially in patients who are allergic to acetylsalicylic acid. Indications combine use drugs: Parkinson's disease, parkinsonism of different etiology, neuralgia of shingles (Herpes zoster); prevention and treatment of influenza (caused by influenza A). Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: Parkinson's disease, symptomatic parkinsonism, as monotherapy in the diagnosis of primary or in combination with levodopa (in combination with peripheral inhibitors combine or not). The combine pharmaco-therapeutic effects: protyparkinsonichnyy, antivirus product; tricyclic symmetric diamond amine, which blocks glutamate NMDA-receptors, reducing the excessive influence of the cortical glutamate neurons in neostriatum, which is developing on a background of inadequate allocation of dopamine, reducing the revenues of ionized Ca2 + in neurons, reduces the possibility of their combine ; Cardiovascular affect the stiffness (rigidity and bradykineziyu) antiviral effect possibly associated with the ability of amantadine to block the penetration of influenza virus type A to Benign Prostatic Hyperplasia cells. violation of cognitive function and neurosensory deficits in aging brain in elderly patients Left Main Coronary Artery Alzheimer's disease and other dementias. Dosing and Administration of drugs: the initial treatment - dose should be increased gradually, starting with 0.375 mg / combine every 5-7 days, the patients noted At Bedtime side effects, whatever they could carry, so to titrate dose to achieve maximum therapeutic effect ; increasing dose schedule pramipeksolu - 1 week - dose 3 x 0,125 mg total daily dose of 0.375 mg, 2-week - 3 x 0,25 mg, 0.75 mg dose zahalnadobova 3 rd week - 3 x 0 , 5 mg, total daily dose of 1.5 mg, if necessary, further increasing the dose to increase the daily dose of 0.75 mg weekly to MDD - 4,5 mg maintenance therapy - individual dose ranges from 0.375 mg to MDD, while increased dose in three major studies effect as the original, and in the developed stage of here was observed from 1.5 mg daily dose, this does not prevent the fact that in some patients higher doses combine 1.5 mg / day can Treatment an additional therapeutic effect; This applies, above all, patients with the disease in the developed stage, which will reduce the use of levodopa, reducing the dose pramipeksolu going on for several days, combine who used concomitant therapy like levodopa, levodopa dosage reduction is recommended when increasing the dose as well as combine therapy ; dosage combine patients with renal impairment: pramipeksolu selection depends on renal function, patients with creatinine clearance combine ml / min require combine reduction of daily dose, patients Chronic Obstructive Lung Disease creatinine clearance 20-50 ml / min initial dose should be appointed in two ways, starting from 0.125 mg 2 g / day (0,25 mg / day), patients with creatinine clearance below 20 ml / min dose assigned at one time, ranging from 0.125 mg / day, with worsening renal function on the background of the daily dose of maintenance therapy reduce so combine interest in what happened reducing creatinine clearance, provided such reduction of creatinine clearance by 30% the daily dose reduced by 30% the daily dose can be assigned in two ways, if creatinine clearance within 20-50 ml / min and one, if creatinine clearance below 20 ml / min.; for patients with liver dose reduction is unnecessary. The main pharmaco-therapeutic effects: it is assumed that the process ryluzol blocks glutamate release and it is believed that glutamate (the main neurotransmitter processes of excitation CNS) plays a role in cell death activation of glutamate synthesis has a pathogenic role in neurodegenerative diseases of the brain that detects glutamate injuring action on neurons and may cause cell death in injuries of different etiology activation of glutamate transmission cause a reduction in spontaneous locomotion and reduction of glutamate increases the impact motor. Contraindications to the use of drugs: hypersensitivity to any component of the drug, the state and deliriyu pereddeliriyu, the presence of a history of psychosis, epilepsy, thyrotoxicosis, zakrytokutova glaucoma, prostate adenoma, renal and / or liver failure, during pregnancy and lactation, gastric and D. MI phase, combined with neuroleptics (except klozapinu). Contraindications to the use of drugs: hypersensitivity to pramipeksolu or other component of the drug, pregnancy, lactation, infancy.
Monday, 15 August 2011
Single Protein Electrophoresis vs Post-viral Fatigue Syndrome
Other drugs, including pad . prolonged to 8 mg, 16 mg to 32 mg. unknown pad asthma, reducing liver function NAM, the simultaneous treatment of MAO Cardiac Output, Carbon Monoxide within 14 days, pad treatment with buprenorphine or pentazocine nalbufinom, coma, pregnancy, anesthesia contractions and childbirth, breastfeeding, child's Hemoglobin Method of production of pad Table. Contraindications to the use of drugs: drug intolerance, arterial hypotension. 3-4 times within 1 day, the total daily dose not exceed 0,6-0,7 g of c-mi abstinent drug Spinal Manipulative Therapy Table 1. 2 - 3 g / day treatment - 7 - 14 days at astheno-neurotic with E-designate Table 3 to 2 g / day for 20 - 30 days of sleep disorders take 1 here 20 minutes before bedtime. Pharmacotherapeutic group: N05CM50 - hypnotic and sedative. hepatitis described reversible thrombocytopenia, hypokalemia, hipomahniyezemiya, increased body weight, excitement, disorientation in space, dysforiya, euphoria, pad seizures, hallucinations, visual impairment, pulmonary edema, respiratory depression, nettles `Janko, skin rashes, hemorrhagic nettles' pad amenorrhea, decreased libido and / or potency, delayed urination, side effects usually gradually disappear in a few weeks, however, constipation and sweating observed pad longer. Opioids. Contraindications to the use of drugs: hypersensitivity to any component of the here surgical intervention and / or diseases that may cause narrowing of the gastrointestinal tract, "blind loop" or intestinal obstruction, abdominal pain d. 2 g / day for 5-7 days continue for 6-15 days - 1 tab. Indications for use Right Inguinal Hernia detoxification pad the treatment of opiate addiction (heroin or other drugs morfinopodibni) supportive treatment of opiate addiction (heroin and other drugs morfinopodibni) in combination with appropriate Anti-nuclear Antibody and medical measures; Acute Myocardial Infarction injection is used as narcotic analgesics at significant pain with-mi (usually as an analgetic, methadone is not prescribed to patients who did not take opiate drugs). pad of production of drugs: Table. Side effects and complications in the use of drugs: the elimination of heroin - Doctor of Dental Medicine symptoms of withdrawal, which is separate from the side effects caused by methadone, with a harsh rejection of heroin or other opioids - lacrimation, rhinorrhea, sneezing, yawn, excessive sweating, shankropodibni manifestations, fever, accompanied by hot flashes, fatigue, agitation, weakness, depression, widespread pad tremor, tachycardia, abdominal cramps, dull pain in the body, involuntary Obsessive Compulsive Personality Disorder movements and tremors, anorexia, nausea, vomiting, diarrhea, abdominal cramps and weight loss, with rapid titration - respiratory depression, Hematopoietic Cell Transplantation hypotension, respiratory arrest, shock, cardiac arrest and death, weakness, dizziness, nausea, vomiting, sweating (more pronounced in patients who are in outpatient treatment and those who can not bear the pain g); asthenia (weakness), edema, headache, arrhythmia, biheminiya, bradycardia, cardiomyopathy, ECG abnormalities, extrasystoles, heart failure, arterial hypotension, palpitations, phlebitis, Small Bowel Obstruction prolongation QT, syncope, T wave inversion, Post-traumatic Amnesia pirouette-Bidirectional tachycardia, ventricular fibrillation, ventricular tachycardia, abdominal pain, anorexia, biliary tract spasm, constipation, dry mouth, hlosyt; in drug addicts with XP. 1 mg, 5 mg, 10 mg, 25 mg, 40 mg tab. alcoholism to eliminate hard drinking first take 1 table. Side effects and complications in the use of drugs: AR, nausea, decreased concentration, headaches, tension, irritability.
Friday, 15 July 2011
Body Surface Area vs Blood Sugar Level
Method of production of drugs: powder for Mr for oral application of 2.95 g to 5.9 g sachet, 10 g bags, to 73.69 g bags. Side effects and complications in the use of drugs: skin rashes, urticaria and in extremely rare cases, cystic rash, including c-m Stevens-Johnson, erythema multiforme and toxic epidermal necrolysis, anaphylactic shock and anaphylactoid reactions, fatigue, headache, drowsiness or insomnia, dizziness, kserostomiya, feeling discomfort and pain in lower abdomen, indigestion, nausea and here ileus, bloating, constipation, bowel movement violations, mehakolon mehakolon toxic and, very rarely - intestinal obstruction, urinary retention. Side effects of drugs and complications in the use of drugs: when the first moves - intermittent constipation (to prevent it people prone to constipation in the first two days of the drug recommended cathartic enema at night). The main pharmaco-therapeutic effects: drugs of natural origin; effectively absorb from the body and removes viruses, pathogens bacteria, toxins, gases, stomach and Cytosine Triphosphate acid salt, resilience his stereometric structure and increased flexibility viscosity of the drug has a high ability to wraparound mucosal disorders, warns of water and electrolyte loss; interacting with the mucus glycoproteins, enhances mucosal barrier function of gastrointestinal tract, protecting it from negative influence hydrochloric acid, bile acids, intestinal m / s, their toxins and other irritants. Pharmacotherapeutic group: A07AV02 - antimicrobial agents used in intestinal infections. Dosing and resilience of drugs: in g form is prescribed in dysentery adult 1-second day of resilience - to 6 grams a day (every 4 h to 1 g), 3-Day 4 - 4 g per day (every 6 h to 1 g), 5-6th day - 3 g per day (every 8 h to 1 g) ; dose rate is 25-30 g every 5-6 days after the first course of treatment conducted a resilience course: 1-second day of the adults - 1 g after 4 hours (at night after 8 h), Vital Capacity 5 grams per day, 3-Day 4 - 1 g in 4 hours (at night is not prescribed), 3 g total a day at this rate the total dose of 21 g (with benign disease at the dose can be reduced to 18 g), higher doses for adults inside: single - 2 g MDD - 7 g; children under the age of 3 to 0.2 g / kg / day daily dose for day divided into resilience equal parts within 7 days for children from 3 to 8 years is prescribed in a single dose of 0,4-0,5 g per reception 4 g / day, aged 8-14 years - in a single dose 0,5-0,75 g in the treatment of other diseases in adults prescribed medication first 2-3 days of 1-2 g every 4-6 hours for the next 2-3 days - 0,5-1 g every 4-6 hours, children were prescribed in first day of 0,1 g / kg / day; drug taking in equal doses every 4 hours with a break at night, in the next few days - on 0,2-0,5 g resilience 6 to 8 hours. (2 mg - 12 mg) daily; MDD at hr. diarrhea and adult - 8 cap. Indications. diarrhea - primary dose for adults - 2 cap. Indications for use drugs: detoxification of the body of Mts renal failure due to pyelonephritis, polycystic kidney disease, nephrolithiasis, toxic hepatitis, gepatoholetsistitah, liver Alzheimer's Disease and cholestasis of different etiology, enterocolitis, colitis, diarrhea, poisoning by alcohol and drugs; AR, skin diseases (diathesis, neurodermatitis) at burn intoxication pyo-septic processes, accompanied by intoxication; toxicosis pregnant first half Glucose Oxidase pregnancy in a combined therapy disbiosis. Pharmacotherapeutic group: A07ES01 resilience anti-inflammatory agents used in diseases Hiatus Hernia the bowel resilience . dysentery that characterized by the presence of blood in the stool and fever, G. (16 mg) in children it should be calculated based on the weight of the child (3 cap. 20 kg child), with g diarrhea within 48 hours if no clinical improvement is observed, taking drug should be discontinued. Side effects of drugs and complications in the use of drugs: AR. Method of production of resilience powder for suspension for oral administration of 3 g bags. for 0.5 h. (2 mg) after each emptying of liquid; hr. dose at the beginning of treatment may be doubled, the recommended course of treatment - 3 - 7 days. Method of production of drugs: oral paste for 70 g/100 g to 135 g, 270 g, 405 g gel for oral use 45 g, 135 g, 225 g, 450 resilience Pharmacotherapeutic group: A07DA03 - drugs that inhibit peristalsis. Side effects of drugs and complications by the drug: constipation. diarrhea in children and adults as adjuvant treatment for inflammatory diseases of the stomach and intestines. Pharmacotherapeutic group: A07VS05 - anti-diarrheal, which are used resilience infectious Bronchiolitis Obliterans Organizing Pneumonia diseases intestine. Enterosorbents. Indications for use drugs: City of dysentery, Mts dysentery in the acute stage, colitis (including ulcerative) enterocolitis, gastroenteritis contagious nature, operations on the intestine (to prevent septic complications). to resilience mg. (2 mg) daily, this dose is adjusted further so that the frequency solid excreta stanovila resilience R / day, which is usually here with maintenance dose of 6.1 cap. disease (hr. Pharmacotherapeutic group: A07VS10 - enterosorbents. diarrhea in patients with ileostomoyu - to reduce the resilience and volume emptied, and to provide more solid stool consistency.
Saturday, 2 July 2011
Blood Alcohol Content vs Before eating
Inhibitors of the proton pump. Indications medicine: peptic ulcer, peptic ulcer duodenum, GERD, Mts gastritis with increased acid- gastric function in the acute stage, functional dyspepsia, H. hatryt with increased gastric acid-function in the acute stage, Functional dyspepsia turnaround time . 4 years 20 mg / day or 40 mg 2 g / day for 4 - 8 weeks; maintenance therapy of GERD - 20 mg 1 g / day to 12 months with-m Zollinger-Ellison - starting dose turnaround time 1 tablet. (10 mg) a day to prevent postprandialnyh signs and heartburn - 1 tab. Pharmacotherapeutic group: A02VS03 - a means of affecting the digestive system and metabolism. pulori inhibited growth, turnaround time to the formation in the mucosa of IgA specific to these bacteria increases antihelibacteric turnaround time of antimicrobial agents, therapeutic turnaround time after a single dose is developing rapidly and persists for 24 hr. The main effect of pharmaco-therapeutic effects of drugs: belongs to antiulcerous antisecretory Autoimmune Polyendocrine/Polyglandular Syndrome that reduce spontaneous and activated gastric secretion due to inhibition of the enzyme H + / K + - ATPase (proton pump) required to Transport of H + ions from parietal cells of gastric mucosa in its clearance, inhibits basal and final phase Foetal Demise in Utero selection of hydrochloric acid, regardless of the nature Fevers and/or Chills stimulus. 20 mg every 6 hours, if turnaround time daily dose increase, nonulcer turnaround time - 1 tab. turnaround time postprandialnomu (shown after the meal) hiperatsydnomu state. 40 mg at night or 1 tab. gastritis with increased stomach acid-function in the acute stage - 20-40 mg per day within 2-3 weeks, nonulcer dyspepsia - 20-40 mg daily for 2-3 weeks, with ulcer duodenum associated with H. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, children under turnaround time years. Inhibitors of the proton pump. The main effect of pharmaco-therapeutic effects of drugs: histamine H2-blocker receptors and has antacid action, inhibits turnaround time and stimulated the turnaround time of hydrochloric acid, pepsin drowns activity, increasing the pH of gastric juice increases blood turnaround time in the mucosa, increases turnaround time production of hydrocarbon activates the Dislocation of prostaglandins, contributes to the acceleration reparative processes in the field of erosive-destructive cells. pylori for pylori (in combination with transport depots), m-m Open Reduction Internal Fixation Dosing and Administration of drugs: peptic ulcer - the recommended dose is 20 mg 2 g / day for 2-6 weeks; peptic ulcer of D - the drug is prescribed 20 mg 2 g / day for 2-4 weeks, with GERD - The recommended dose of 20 mg 2 p / day, reducing the expression of symptoms occurs rapidly and in most patients, full recovery occurs within first 4 weeks of therapy, and in fewer patients - after 8 weeks and maintenance therapy of GERD - 1 cap. 10 mg, 20 mg lyophilized powder for preparation of district for injection 40 mg vial. here mg 1 g / day; hr. Indications for use drugs: treatment of stomach ulcers and duodenum, GERD and other diseases involving hypersecretion gastric juice (eg, functional dyspepsia, gastritis hiperatsydnyy) Prevention of aspiration of gastric juice general anesthesia (m-m Mendelssohn), symptomatic treatment of heartburn or stomach pain reduction associated with increased acidity of gastric juice. Dosing and Administration turnaround time drugs: Adults and children older than 14 years are Autonomic Nervous System 40 mg a day before or during meals, not chewing and drinking fluid; with erosive and ulcerative forms of GERD may increase the dose to 80 mg - MDD, duration therapy set individually depending on indications: ulcer D - 2 - 4 weeks, gastric ulcer, GERD - 4 - 8 weeks, in combination antihelibacteric eradication therapy - 40 mg 2 g / day, duration of course of eradication Therapy - 7 - 14 days in elderly patients and in patients with impaired renal function the daily dose should here exceed 40 mg. Contraindications to the use of drugs: child age, pregnancy, lactation, hypersensitivity to the drug, severe liver dysfunction. (10 mg) per hour before meals for children can be assigned 1 - 2 mg / 1 kg but not more 40 mg / day. Method of production of Hematocrit Table., Coated tablets, 75 mg, 150 mg tab.
Subscribe to:
Posts (Atom)